CVSA Covista Inc. Common Shares
NYSE · Diversified Consumer Services · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 6, 2026CVSA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
CVSA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
| Ex-date | Split | Type |
|---|---|---|
| June 22, 1998 | 2-for-1 | Forward |
| Dec. 19, 1996 | 2-for-1 | Forward |
| June 22, 1995 | 2-for-1 | Forward |
About Covista Inc. Common Shares Company overview from Wikipedia
Covista Inc., previously Adtalem Global Education Inc. and, before that, the DeVry Education Group, is a US corporation based in Chicago, Illinois, that operates for-profit higher education institutions, including American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine, and Walden University.
Before June 2018, the corporation was known as DeVry Education Group Inc. Following a $100 million settlement with the FTC in 2016 regarding deceptive advertising, DeVry Education Group rebranded as Adtalem Global Education in 2017. Adtalem began the process to sell off DeVry University and Keller Graduate School of Management later that year to focus on healthcare professional education. Adtalem subsequently renamed itself Covista in 2026.
History
DeVry Inc. was created in 1987 with the merger of DeVry Institute of Technology (DIT) and the Keller Graduate School of Management. DIT was established in Chicago as the DeForest Training School in 1931 and was acquired by Bell & Howell in 1967. Keller was started by two DIT teachers in 1973; the company acquired DIT from Bell & Howell in 1987. DeVry Inc. went public in 1991, moved to the New York Stock Exchange in 1995, and became known as DeVry Education Group in 2013. The company was previously based in Downers Grove, Illinois.
In 2012, the company moved 150 jobs from its campus in Roscoe Village to a new office in Chicago's West Loop. The company had additional offices in Oak Brook, as of 2013. In 2015, the company opened another office in the West Loop, after the city approved a $1 million subsidy for the company in the form of tax increment financing in 2012.
In November 2013, DeVry Inc. was renamed DeVry Education Group.
Adtalem agreed to purchase Walden University for approximately $1.5 billion in September 2020. The agreement required approval by the U.S. Department of Education and the Higher Learning Commission. When the deal closed in August 2021, Adtalem became the largest provider of graduate and undergraduate degrees in nursing.
Rebranding from DeVry Education Group to Adtalem Global Education
Following a $100 million settlement with the FTC in 2016 regarding deceptive advertising, DeVry Education Group rebranded as Adtalem Global Education in 2017 and began the process to sell off DeVry University and Keller Graduate School of Management later that year. Industry analysts characterized the move as an effort to move on from DeVry's legal, financial and reputational challenges.
The company's headquarters were later relocated from Downers Grove to 500 West Monroe Street in the West Loop Gate. In 2024, Crain's Chicago Business said Adtalem had become "the largest health care educator in the nation during a post-COVID period in which the health care sector has faced severe labor shortages".
Operations
Campuses and enrollment
Adtalem's institutions operated approximately 130 campuses globally in 2018. Twelve of the 90 U.S. campuses were located in Illinois. In 2020, Adtalem's businesses operated 26 campuses in four countries and fifteen U.S. states. Approximately 90,000 students attended schools with a combined 6,100 faculty members. As of 2021, approximately 82 percent of the 140,000 students enrolled at Adtalem schools learned via distance education. In 2022, Adtalem operated 27 campuses and offered courses in 209 countries and territories.
In 2026, Covista and Advocate Health partnered to create a pipeline to place nursing graduates in the latter's hospitals. The collaboration is focused on Chamberlain University and seeks to address the nation's nursing shortage.
Leadership
Stephen Beard, who was previously Adtalem's chief operating officer, became the chief executive officer (CEO) in 2021. He was appointed the chair of the board of directors in November 2024, succeeding Michael W. Malafronte. Beard was included in Time magazine's 2025 "Time100 Health" list of influential people in the healthcare industry.
Chris Begley was the board chair in 2016. Daniel Hamburger and Lisa Wardell have previously held the CEO role. Wardell was appointed in 2016. She was the only Black woman to lead a Fortune 1000 company in 2018, according to Crain's Chicago Business. Wardell was also the board chair in 2019. In 2021, an analysis by the University of Illinois Urbana-Champaign ranked Adtalem in the top five Illinois-based public firms for both gender and racial diversity on the board.
Finances
In December 2016, DeVry Education Group agreed to a $100 million settlement of a lawsuit regarding deceptive advertising filed by the U.S Federal Trade Commission. Under the settlement, the group agreed to pay $49.4 million in cash to students and forgive $50.6 million in loans to students. In 2017, Adtalem lost approximately $4.6 million from the impacts of Hurricane Irma and Hurricane Maria. The company made a profit of $95.6 million in 2019 and lost $85.8 million in 2020, suffering from enrollment declines during the COVID-19 pandemic. In early 2024, Adtalem was targeted by a short seller and the company announced a $300 million repurchase program. In late 2024, Investor's Business Daily said Adtalem saw an average sales growth of fourteen percent over the last three years. For the 2024 fiscal year, Adtalem repurchased 5.446 million shares for approximately $261 million. In May 2025, the repurchase was completed and a new stock buyback program of up to $150 million through May 2028 was launched.
Controversies
Covista, formerly known as DeVry Education Group, has been the subject of numerous investigations and lawsuits alleging that a variety of false or deceptive practices. While the group has generally denied the allegations, several cases led to multi-million dollar settlements.
In December 2016, DeVry Education Group agreed to a $100 million settlement of a lawsuit regarding deceptive advertising filed by the U.S Federal Trade Commission. Under the settlement, the group agreed to pay $49.4 million in cash to students and forgive $50.6 million in loans to students.
Months after the FTC settlement, DeVry Education Group rebranded as Adtalem Global Education in May 2018. Adtalem rebranded as Covista in 2026.
For-profit higher education in the United States has been the subject of hearings by the United States Senate Committee on Health, Education, Labor, and Pensions. Specifically regarding DeVry, the Committee found that over half of the students enrolled at DeVry in 2008-2009 withdrew by mid-2010. As of 2015, DeVry spent more on marketing than on student instruction.
As of 2013, DeVry Inc. was under investigation by the Attorneys General of the states of Illinois and Massachusetts.
In 2014, accumulated student loan debt from DeVry University and Keller, its graduate school, had reached approximately $12.1 billion.
A lawsuit filed against DeVry alleged deceptive recruiting practices in violation of federal law.
In January 2016, The Federal Trade Commission filed a lawsuit against DeVry Education Group alleging false or misleading advertising. A class action lawsuit was also filed against DeVry Group in US District Court, Northern District of California claiming breaches of contract, good faith and fair dealing, violations of the California Unfair Trade Practices Act, the California False Advertising Act and the California Consumer Legal Remedies Act, and negligent misrepresentations. A confidential settlement was reached.
In May 2016, a shareholder class action lawsuit was filed against DeVry Group, in the US District Court, Northern District of Illinois. The plaintiffs claimed that defendants made false or misleading statements regarding DeVry University's graduate employment rate and the earnings of DeVry University graduates relative to the graduates of other universities and colleges. The case was settled in 2019 for $27.5 million.
In December 2017, a former administrator filed a civil lawsuit number with the Los Angeles Superior Court, seeking relief for a number of causes of action including Retaliation and Wrongful Termination in Violation of Public Policy for complaining about an incentive-based compensation program that rewarded campus deans for recruiting and enrolling students.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | CVSA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 17.85Y avg ≈18.8 | ≈18.8 | · | · | |
| P/S (TTM) | 2.25Y avg ≈1.8 | ≈1.8 | · | · | |
| P/B (MRQ) | 3.05Y avg ≈2.2 | ≈2.2 | · | · | |
| EV / EBITDA | 11.85Y avg ≈12.8 | ≈12.8 | · | · | |
| Price / FCF (TTM) | 10.95Y avg ≈11.5 | ≈11.5 | · | · | |
| Price / Cash Flow (TTM) | 9.15Y avg ≈9.6 | ≈9.6 | · | · | |
| EV / Revenue | 2.35Y avg ≈2.1 | ≈2.1 | · | · | |
| EV / FCF | 11.55Y avg ≈13.0 | ≈13.0 | · | · | |
| Price / Tangible Book (MRQ) | 6.2 | · | · | · | |
| PEG Ratio | ≈0.5 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | CVSA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | 19.6%5Y avg ≈16.0% | ≈16.0% | · | · | |
| EBITDA Margin | 19.6%5Y avg ≈16.0% | ≈16.0% | · | · | |
| Pretax Margin (TTM) | 17.7%5Y avg ≈13.1% | ≈13.1% | · | · | |
| Net Profit Margin (TTM) | 12.9%5Y avg ≈10.3% | ≈10.3% | · | · | |
| ROA (TTM) | 8.7%5Y avg ≈6.4% | ≈6.4% | · | · | |
| ROE (TTM) | 17.5%5Y avg ≈12.7% | ≈12.7% | · | · | |
| ROIC | 14.1%5Y avg ≈10.9% | ≈10.9% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | CVSA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity | 0.55Y avg ≈0.4 | ≈0.4 | · | · | |
| Current Ratio (MRQ) | 1.15Y avg ≈1.0 | ≈1.0 | · | · | |
| Quick Ratio | 1.05Y avg ≈0.8 | ≈0.8 | · | · | |
| Long-Term Debt / Equity (MRQ) | 0.55Y avg ≈0.4 | ≈0.4 | · | · | |
| Interest Coverage | 8.45Y avg ≈5.3 | ≈5.3 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | CVSA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 9.3%5Y avg ≈9.1% | ≈9.1% | · | · | |
| Revenue CAGR 3Y | 10.4%5Y avg ≈14.7% | ≈14.7% | · | · | |
| Revenue CAGR 5Y | 16.8% | · | · | · | |
| EPS YoY | 13.9%5Y avg ≈23.4% | ≈23.4% | · | · | |
| Net Income YoY | 6.1%5Y avg ≈14.0% | ≈14.0% | · | · | |
| EPS CAGR 3Y | 50.9%5Y avg ≈28.4% | ≈28.4% | · | · | |
| EPS CAGR 5Y | 38.9% | · | · | · | |
| Net Income CAGR 3Y | 39.2%5Y avg ≈18.5% | ≈18.5% | · | · | |
| Net Income CAGR 5Y | 29.1% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | CVSA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.75Y avg ≈0.6 | ≈0.6 | · | · | |
| Receivables Turnover | 12.65Y avg ≈14.1 | ≈14.1 | · | · | |
| Revenue / Employee | ≈$412.6K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
| Ex-date | Amount | Currency | Yield |
|---|---|---|---|
| Nov 30, 2016 | $0.18 | USD | ≈1.2% |
| Jun 1, 2016 | $0.18 | USD | ≈2.0% |
| Dec 2, 2015 | $0.18 | USD | ≈1.5% |
| Jun 3, 2015 | $0.18 | USD | ≈1.1% |
| Dec 3, 2014 | $0.18 | USD | ≈0.72% |
| Jun 4, 2014 | $0.17 | USD | ≈0.81% |
| Dec 4, 2013 | $0.17 | USD | ≈0.96% |
| Jun 5, 2013 | $0.17 | USD | ≈1.1% |
| Nov 28, 2012 | $0.17 | USD | ≈1.2% |
| Jun 19, 2012 | $0.15 | USD | ≈1.1% |
| Dec 6, 2011 | $0.15 | USD | ≈0.76% |
| Jun 16, 2011 | $0.12 | USD | ≈0.42% |
| Dec 8, 2010 | $0.12 | USD | ≈0.50% |
| Jun 11, 2010 | $0.10 | USD | ≈0.35% |
| Dec 9, 2009 | $0.10 | USD | ≈0.31% |
| Jun 12, 2009 | $0.08 | USD | ≈0.34% |
| Dec 10, 2008 | $0.08 | USD | ≈0.26% |
| Jun 17, 2008 | $0.06 | USD | ≈0.20% |
| Dec 12, 2007 | $0.06 | USD | ≈0.19% |
| Jun 14, 2007 | $0.05 | USD | ≈0.28% |
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | $2.09 | $1.93 | 8.3% | |
| March 31, 2026 | $1.98 | $1.76 | 12.7% | |
| Dec. 31, 2025 | $2.43 | $2.23 | 8.9% | |
| Sept. 30, 2025 | $1.75 | $1.61 | 8.8% | |
| June 30, 2025 | $1.66 | $1.56 | 6.2% | |
| March 31, 2025 | $1.92 | $1.69 | 13.9% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.95B | $1.79B | $1.58B | $1.45B | $1.38B | · | · | · | |
| Cost of Revenue | $834M | $771M | $699M | $648M | $660M | · | · | · | |
| SG&A Expense | $731M | $672M | $633M | $586M | $566M | · | · | · | |
| Operating Expenses | $1.57B | $1.45B | $1.37B | $1.28B | $1.31B | · | · | · | |
| Operating Income | $383M | $342M | $217M | $168M | $77M | · | · | · | |
| Interest Expense | $45M | $52M | $64M | $63M | $129M | · | · | · | |
| Interest Income | · | · | · | · | $4M | · | · | · | |
| Other Non-op | $7M | $9M | $11M | $7M | $1M | · | · | · | |
| Pretax Income | $345M | $299M | $164M | $112M | $-51M | · | · | · | |
| Income Tax | $78M | $66M | $26M | $10M | $-16M | · | · | · | |
| Net Income | $252M | $237M | $137M | $93M | $311M | · | · | · | |
| EPS (Basic) | $7.18 | $6.39 | $3.47 | $2.08 | $6.43 | · | · | · | |
| EPS (Diluted) | $7.04 | $6.18 | $3.39 | $2.05 | $6.43 | · | · | · | |
| Shares (Basic) | 35,045,000 | 37,085,000 | 39,413,000 | 44,781,000 | 48,388,000 | · | · | · | |
| Shares (Diluted) | 35,715,000 | 38,334,000 | 40,307,000 | 45,600,000 | 48,388,000 | · | · | · | |
| EBITDA | $383M | $342M | $217M | $168M | $80M | · | · | · |
Balance Sheet
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $406M | $200M | $219M | $272M | $347M | $275M | $416M | $67M | |
| Short-term Investments | · | · | · | · | · | · | · | $9M | |
| Receivables | $167M | $143M | $124M | $100M | $79M | $90M | $69M | · | |
| Prepaid Expense | $75M | $69M | $70M | $102M | $128M | $167M | $97M | $45M | |
| Current Assets | $652M | $416M | $418M | $480M | $557M | $611M | $681M | $390M | |
| PP&E (Net) | $303M | $256M | $249M | $245M | $290M | $302M | $279M | $282M | |
| PP&E (Gross) | $686M | $598M | $575M | $583M | $666M | $663M | $618M | $605M | |
| Accum. Depreciation | $383M | $342M | $326M | $339M | $376M | $362M | $339M | $323M | |
| Goodwill | $961M | $961M | $961M | $961M | $961M | $960M | $310M | $687M | |
| Intangibles | $754M | $765M | $777M | $812M | $874M | $924M | $138M | $293M | |
| Other Non-current Assets | $138M | $129M | $103M | $81M | $119M | $118M | $88M | $83M | |
| Total Assets | $3.01B | $2.75B | $2.74B | $2.81B | $3.03B | $3.66B | $2.27B | $2.39B | |
| Accounts Payable | $125M | $105M | $103M | $82M | $57M | $65M | $39M | $31M | |
| Accrued Liabilities | $94M | $77M | $97M | $106M | $98M | $135M | $97M | $90M | |
| Current Liabilities | $597M | $508M | $488M | $431M | $424M | $497M | $341M | $304M | |
| Capital Leases | $208M | $186M | $168M | $163M | $177M | $156M | $194M | $180M | |
| Deferred Tax | $62M | $32M | $30M | $26M | $26M | $27M | $25M | $25M | |
| Other Non-current Liabilities | $42M | $40M | $39M | $37M | $74M | $58M | $81M | $89M | |
| Total Liabilities | $1.57B | $1.32B | $1.37B | $1.35B | $1.54B | $2.37B | $959M | $1.09B | |
| Long-term Debt | $663M | $553M | $649M | $695M | $839M | $1.61B | $287M | $415M | |
| Total Debt | $663M | $553M | $649M | $695M | $839M | · | · | · | |
| Common Stock | $848.0K | $839.0K | $832.0K | $822.0K | $818.0K | $817.0K | $810.0K | $806.0K | |
| Retained Earnings | $3.03B | $2.78B | $2.54B | $2.40B | $2.31B | $1.96B | $1.97B | $2.03B | |
| Treasury Stock | $2.29B | $2.01B | $1.78B | $1.51B | $1.34B | $1.22B | $1.16B | $1.08B | |
| AOCI | $-2M | $-2M | $-2M | $-2M | $-2M | $-634.0K | $-8M | $-159M | |
| Stockholders' Equity | $1.45B | $1.43B | $1.37B | $1.46B | $1.49B | $1.28B | $1.31B | $1.29B | |
| Liabilities + Equity | $3.01B | $2.75B | $2.74B | $2.81B | $3.03B | $3.66B | $2.27B | $2.39B | |
| Shares Outstanding | 34,033,000 | 35,952,000 | 37,681,000 | 82,232,000 | 81,796,000 | 81,705,000 | 81,021,000 | 52,953,000 |
Cash Flow
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $41M | $42M | $26M | $14M | $23M | · | · | · | |
| Deferred Tax | $68M | $18M | $11M | $-5M | $-14M | · | · | · | |
| Amort. of Intangibles | $11M | $11M | $36M | $61M | $97M | · | · | · | |
| Restructuring | $6M | $3M | $2M | $19M | $26M | · | · | · | |
| Operating Cash Flow | $470M | $338M | $296M | $192M | $11M | · | · | · | |
| CapEx | $78M | $50M | $49M | $26M | $31M | · | · | · | |
| Investing Cash Flow | $-84M | $-42M | $-48M | $24M | $-552M | · | · | · | |
| Debt Issued | $1.01B | $10M | $2M | $0 | $850M | · | · | · | |
| Net Debt Issued | $112M | $-100M | $-50M | $-151M | $-230M | · | · | · | |
| Stock Repurchased | $240M | $213M | $262M | $123M | $120M | · | · | · | |
| Net Stock Activity | $-240M | $-213M | $-262M | $-123M | $-120M | · | · | · | |
| Financing Cash Flow | $-180M | $-316M | $-302M | $-289M | $-424M | · | · | · | |
| Net Change in Cash | $207M | $-20M | $-54M | $-73M | $-966M | · | · | · | |
| Taxes Paid | $14M | $33M | $31M | $12M | $94M | · | · | · | |
| Free Cash Flow | $393M | $288M | $247M | $166M | $-21M | · | · | · | |
| Levered FCF | $358M | $247M | $193M | $109M | $-106M | · | · | · |
Profitability
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 19.6% | 19.1% | 13.7% | 11.6% | 5.8% | · | · | · | |
| Net Margin | 12.9% | 13.3% | 8.6% | 6.4% | 22.9% | · | · | · | |
| Pretax Margin | 17.7% | 16.7% | 10.3% | 7.7% | -3.2% | · | · | · | |
| EBITDA Margin | 19.6% | 19.1% | 13.7% | 11.6% | 5.8% | · | · | · | |
| ROA | 8.7% | 8.6% | 4.9% | 3.3% | 9.7% | · | · | · | |
| ROE | 17.8% | 16.5% | 10.2% | 6.3% | 21.3% | · | · | · | |
| ROIC | 14.1% | 13.4% | 9.0% | 7.1% | 2.3% | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 0.8 | 0.9 | 1.1 | 1.3 | · | · | · | |
| Quick Ratio | 1.0 | 0.7 | 0.7 | 0.9 | 1.0 | · | · | · | |
| Debt / Equity | 0.5 | 0.4 | 0.5 | 0.5 | 0.6 | · | · | · | |
| LT Debt / Equity | 0.5 | 0.4 | 0.5 | 0.5 | 0.6 | · | · | · | |
| Interest Coverage | 8.4 | 6.5 | 3.4 | 2.7 | 0.6 | · | · | · |
Efficiency
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | 0.6 | 0.5 | 0.4 | · | · | · | |
| Receivables Turnover | 12.6 | 13.4 | 14.1 | 16.2 | 16.1 | · | · | · |
Per Share
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $42.49 | $39.88 | $36.33 | $34.44 | $33.31 | · | · | · | |
| Revenue / Share | $54.71 | $46.65 | $39.31 | $31.82 | $28.67 | · | · | · | |
| Cash Flow / Share | $13.17 | $8.81 | $7.34 | $4.45 | $0.22 | · | · | · | |
| Cash / Share | $11.94 | $5.55 | $5.82 | $6.47 | $7.68 | · | · | · | |
| EPS (TTM) | $7.04 | $6.18 | $3.39 | $2.05 | $6.43 | · | · | · |
Growth Rates
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.3% | 12.8% | 9.2% | 5.0% | 53.7% | · | · | · | |
| Revenue CAGR 3Y | 10.4% | 9.0% | 20.8% | 18.8% | · | · | · | · | |
| Revenue CAGR 5Y | 16.8% | 15.6% | · | · | · | · | · | · | |
| EPS YoY | 13.9% | 82.3% | 65.4% | -68.1% | 372.8% | · | · | · | |
| EPS CAGR 3Y | 50.9% | -1.3% | 35.6% | · | · | · | · | · | |
| EPS CAGR 5Y | 38.9% | · | · | · | · | · | · | · | |
| Net Income YoY | 6.1% | 73.3% | 46.5% | -70.0% | 344.1% | · | · | · | |
| Net Income CAGR 3Y | 39.2% | -8.6% | 25.0% | · | · | · | · | · | |
| Net Income CAGR 5Y | 29.1% | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.95B | $1.79B | $1.58B | $1.45B | $1.38B | · | · | · | |
| Net Income TTM | $252M | $237M | $137M | $93M | $311M | · | · | · | |
| Market Cap | $4.24B | $4.57B | $2.57B | $1.45B | $1.63B | · | · | · | |
| Enterprise Value | $4.50B | $4.93B | $3.00B | $1.87B | $2.12B | · | · | · | |
| P/E | 17.7 | 20.6 | 20.1 | 16.8 | 5.6 | · | · | · | |
| P/S | 2.2 | 2.6 | 1.6 | 1.0 | 1.2 | · | · | · | |
| P/B | 2.9 | 3.2 | 1.9 | 1.0 | 1.1 | · | · | · | |
| P / Cash Flow | 9.0 | 13.5 | 8.7 | 7.2 | 155.9 | · | · | · | |
| P / FCF | 10.8 | 15.9 | 10.4 | 8.8 | -78.8 | · | · | · | |
| EV / EBITDA | 11.7 | 14.4 | 13.8 | 11.1 | 26.3 | · | · | · | |
| EV / FCF | 11.5 | 17.1 | 12.2 | 11.3 | -102.6 | · | · | · | |
| EV / Revenue | 2.3 | 2.8 | 1.9 | 1.3 | 1.5 | · | · | · | |
| Earnings Yield | 5.7% | 4.9% | 5.0% | 6.0% | 17.9% | · | · | · |
Income Statement
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $501M | $487M | $503M | $462M | $457M | $466M | $448M | $417M | $410M | $413M | $393M | $369M | $365M | $369M | $363M | $354M | |
| Cost of Revenue | $217M | $211M | $205M | $201M | $199M | $200M | $187M | $186M | $183M | $175M | $172M | $169M | $164M | $166M | $159M | $160M | |
| SG&A Expense | $188M | $184M | $183M | $176M | $181M | $175M | $157M | $159M | $155M | $157M | $156M | $166M | $153M | $145M | $142M | $146M | |
| Operating Expenses | $406M | $396M | $392M | $377M | $380M | $376M | $344M | $347M | $341M | $351M | $335M | $341M | $325M | $310M | $317M | $331M | |
| Operating Income | $95M | $91M | $111M | $85M | $77M | $91M | $104M | $70M | $69M | $62M | $59M | $28M | $40M | $59M | $46M | $24M | |
| Interest Expense | $10M | $14M | $11M | $11M | $11M | $13M | $14M | $14M | $15M | $17M | $17M | $16M | $15M | $14M | $16M | $18M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | · | · | $3M | $2M | $2M | |
| Other Non-op | $3M | $232.0K | $2M | $2M | $3M | $2M | $2M | $3M | $2M | $3M | $4M | $2M | $4M | $4M | $-1M | $761.0K | |
| Pretax Income | $88M | $78M | $102M | $77M | $69M | $79M | $92M | $58M | $56M | $48M | $45M | $15M | $28M | $49M | $29M | $7M | |
| Income Tax | $16M | $20M | $26M | $16M | $14M | $19M | $21M | $12M | $5M | $11M | $8M | $3M | $4M | $389.0K | $4M | $1M | |
| Net Income | $72M | $42M | $76M | $62M | $54M | $61M | $76M | $46M | $49M | $37M | $40M | $11M | $22M | $46M | $25M | $592.0K | |
| EPS (Basic) | $2.12 | $1.21 | $2.14 | $1.71 | $1.50 | $1.64 | $2.03 | $1.22 | $1.26 | $0.95 | $1.00 | $0.26 | $0.51 | $1.02 | $0.54 | $0.01 | |
| EPS (Diluted) | $2.06 | $1.20 | $2.11 | $1.67 | $1.43 | $1.59 | $1.98 | $1.18 | $1.23 | $0.93 | $0.98 | $0.25 | $0.51 | $1.00 | $0.53 | $0.01 | |
| Shares (Basic) | · | 34,283,000 | 35,725,000 | 36,111,000 | · | 37,140,000 | 37,435,000 | 37,721,000 | · | 38,713,000 | 39,872,000 | 41,399,000 | · | 45,125,000 | 45,425,000 | 45,274,000 | |
| Shares (Diluted) | · | 34,782,000 | 36,230,000 | 37,057,000 | · | 38,233,000 | 38,401,000 | 39,109,000 | · | 39,636,000 | 40,787,000 | 42,184,000 | · | 45,801,000 | 46,121,000 | 46,342,000 | |
| EBITDA | · | $91M | $111M | $85M | · | $91M | $104M | $70M | · | $62M | $59M | $28M | · | $59M | $46M | $23M |
Balance Sheet
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $406M | $147M | $56M | $265M | $200M | $219M | $194M | $265M | $219M | $180M | $183M | $262M | · | $315M | $208M | $328M | |
| Receivables | $167M | $173M | $160M | $192M | $143M | $160M | $144M | $169M | $124M | $138M | $131M | $145M | · | $111M | $97M | $109M | |
| Prepaid Expense | $75M | $79M | $81M | $106M | $69M | $66M | $65M | $79M | $70M | $59M | $58M | $61M | · | $103M | $114M | $128M | |
| Current Assets | $652M | $404M | $303M | $567M | $416M | $450M | $407M | $517M | $418M | $388M | $378M | $473M | · | $533M | $423M | $570M | |
| PP&E (Net) | $303M | $277M | $266M | $257M | $256M | $251M | $246M | $245M | $249M | $273M | $260M | $265M | · | $253M | $276M | $282M | |
| PP&E (Gross) | $686M | $649M | $627M | $608M | $598M | $583M | $583M | $574M | $575M | $600M | $605M | $609M | · | $583M | $621M | $646M | |
| Accum. Depreciation | $383M | $372M | $361M | $351M | $342M | $332M | $337M | $329M | $326M | $327M | $345M | $345M | · | $330M | $346M | $364M | |
| Goodwill | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | · | $961M | $961M | $961M | |
| Intangibles | $754M | $757M | $760M | $763M | $765M | $768M | $771M | $774M | $777M | $784M | $792M | $802M | · | $825M | $839M | $855M | |
| Other Non-current Assets | $138M | $137M | $135M | $129M | $129M | $120M | $113M | $108M | $103M | $68M | $66M | $68M | · | $68M | $117M | $121M | |
| Total Assets | $3.01B | $2.74B | $2.61B | $2.87B | $2.75B | $2.79B | $2.72B | $2.82B | $2.74B | $2.72B | $2.70B | $2.79B | · | $2.87B | $2.84B | $3.00B | |
| Accounts Payable | $125M | $97M | $103M | $105M | $105M | $99M | $67M | $91M | $103M | $92M | $88M | $77M | · | $73M | $71M | $64M | |
| Accrued Liabilities | $94M | $93M | $72M | $63M | $77M | $86M | $62M | $87M | $97M | $114M | $98M | $89M | · | $87M | $94M | $94M | |
| Current Liabilities | $597M | $580M | $443M | $577M | $508M | $541M | $385M | $551M | $488M | $509M | $399M | $496M | · | $438M | $371M | $491M | |
| Capital Leases | $208M | $202M | $191M | $188M | $186M | $193M | $182M | $162M | $168M | $160M | $169M | $161M | · | $164M | $166M | $165M | |
| Deferred Tax | $62M | $59M | $57M | $53M | $32M | $34M | $32M | $30M | $30M | $29M | $27M | $26M | · | $27M | $27M | $26M | |
| Other Non-current Liabilities | $42M | $37M | $41M | $38M | $40M | $37M | $35M | $35M | $39M | $48M | $41M | $37M | · | $33M | $62M | $63M | |
| Total Liabilities | $1.57B | $1.37B | $1.24B | $1.41B | $1.32B | $1.36B | $1.28B | $1.43B | $1.37B | $1.39B | $1.33B | $1.42B | · | $1.36B | $1.32B | $1.49B | |
| Long-term Debt | $663M | $499M | $504M | $553M | $553M | $552M | $650M | $649M | $649M | $648M | $696M | $696M | · | $694M | $694M | $742M | |
| Total Debt | · | $499M | $504M | $553M | · | $552M | $650M | $649M | · | $648M | $696M | $696M | · | $694M | $694M | $742M | |
| Common Stock | $848.0K | $847.0K | $847.0K | $847.0K | $839.0K | $839.0K | $839.0K | $838.0K | $832.0K | $831.0K | $831.0K | $826.0K | · | $822.0K | $822.0K | $821.0K | |
| Retained Earnings | $3.03B | $2.96B | $2.92B | $2.84B | $2.78B | $2.72B | $2.66B | $2.59B | $2.54B | $2.49B | $2.45B | $2.41B | · | $2.38B | $2.35B | $2.33B | |
| Treasury Stock | $2.29B | $2.29B | $2.22B | $2.05B | $2.01B | $1.94B | $1.87B | $1.83B | $1.78B | $1.77B | $1.68B | $1.61B | · | $1.43B | $1.39B | $1.34B | |
| AOCI | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | · | $-2M | $-2M | $-2M | |
| Stockholders' Equity | $1.45B | $1.36B | $1.38B | $1.46B | $1.43B | $1.43B | $1.44B | $1.39B | $1.37B | $1.32B | $1.37B | $1.38B | $1.46B | $1.51B | $1.52B | $1.51B | |
| Liabilities + Equity | $3.01B | $2.74B | $2.61B | $2.87B | $2.75B | $2.79B | $2.72B | $2.82B | $2.74B | $2.72B | $2.70B | $2.79B | · | $2.87B | $2.84B | $3.00B | |
| Shares Outstanding | 34,033,000 | 34,023,000 | 34,654,000 | 36,324,000 | 35,952,000 | 36,512,000 | 37,289,000 | 37,716,000 | 37,681,000 | 37,765,000 | 39,526,000 | 40,401,000 | 82,232,000 | 44,232,000 | 45,443,000 | 45,396,000 |
Cash Flow
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $10M | $10M | $13M | $8M | $10M | $10M | $11M | $9M | $7M | $6M | $6M | $7M | $3M | $3M | $2M | $6M | |
| Amort. of Intangibles | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $7M | $8M | $9M | $11M | $12M | $14M | $16M | $19M | |
| Restructuring | $1M | $863.0K | $4M | $310.0K | $388.0K | $510.0K | $322.0K | $2M | $653.0K | $473.0K | $68.0K | $676.0K | $1M | $1M | $1M | $15M | |
| Operating Cash Flow | $124M | $186M | $30M | $131M | $60M | $208M | $-19M | $89M | $60M | $143M | $-18M | $95M | $42M | $108M | $-50M | $91M | |
| CapEx | $27M | $20M | $15M | $16M | $19M | $10M | $11M | $10M | $17M | $2M | $5M | $10M | $7M | $9M | $4M | $5M | |
| Investing Cash Flow | $-28M | $-20M | $-20M | $-16M | $-12M | $-10M | $-11M | $-10M | $-16M | $-2M | $-5M | $-10M | $-7M | $44M | $-7M | $-6M | |
| Debt Issued | $163M | $617M | · | · | $0 | $0 | $0 | $10M | $0 | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | $0 | · | · | · | $0 | · | · | · | $-101M | |
| Stock Repurchased | $0 | $68M | $165M | $8M | $67M | $72M | $41M | $33M | $12M | $90M | $70M | $90M | $78M | · | · | $0 | |
| Net Stock Activity | · | · | · | $-8M | · | · | · | $-33M | · | · | · | $-90M | · | · | · | · | |
| Financing Cash Flow | $163M | $-76M | $-218M | $-50M | $-68M | $-172M | $-42M | $-34M | $-11M | $-140M | $-56M | $-95M | $-78M | $-44M | $-63M | $-103M | |
| Net Change in Cash | $259M | $90M | $-208M | $65M | $-20M | $26M | $-71M | $46M | $34M | $1M | $-78M | $-11M | $-42M | $107M | $-120M | $-18M | |
| Free Cash Flow | · | · | · | $115M | · | · | · | $79M | · | · | · | $85M | · | · | · | $86M | |
| Levered FCF | · | · | · | $106M | · | · | · | $67M | · | · | · | $72M | · | · | · | $71M |
Profitability
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | 18.8% | 22.1% | 18.5% | · | 19.4% | 23.2% | 16.8% | · | 15.0% | 14.9% | 7.6% | · | 16.1% | 12.7% | 6.5% | |
| Net Margin | · | 8.6% | 15.2% | 13.4% | · | 13.1% | 16.9% | 11.1% | · | 8.9% | 10.1% | 2.9% | · | 12.4% | 6.7% | 0.62% | |
| Pretax Margin | · | 16.0% | 20.2% | 16.6% | · | 17.0% | 20.6% | 14.0% | · | 11.6% | 11.6% | 4.0% | · | 13.3% | 7.7% | 1.9% | |
| EBITDA Margin | · | 18.8% | 22.1% | 18.5% | · | 19.4% | 23.2% | 16.8% | · | 15.0% | 14.9% | 7.6% | · | 16.1% | 12.7% | 6.5% | |
| ROA | · | 1.5% | 2.9% | 2.2% | · | 2.2% | 2.8% | 1.7% | · | 1.3% | 1.4% | 0.37% | · | 1.4% | 0.74% | 0.06% | |
| ROE | · | 3.0% | 5.4% | 4.3% | · | 4.4% | 5.4% | 3.3% | · | 2.6% | 2.8% | 0.74% | · | 3.1% | 1.7% | 0.16% | |
| ROIC | · | 3.6% | 4.4% | 3.4% | · | 3.5% | 3.8% | 2.7% | · | 2.4% | 2.4% | 1.1% | · | 2.7% | 1.8% | 0.87% |
Liquidity & Solvency
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 0.7 | 0.7 | 1.0 | · | 0.8 | 1.1 | 0.9 | · | 0.8 | 0.9 | 1.0 | · | 1.2 | 1.1 | 1.2 | |
| Quick Ratio | · | 0.6 | 0.5 | 0.8 | · | 0.7 | 0.9 | 0.8 | · | 0.6 | 0.8 | 0.8 | · | 1.0 | 0.8 | 0.9 | |
| Debt / Equity | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | |
| LT Debt / Equity | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | |
| Interest Coverage | · | 6.7 | 10.2 | 7.7 | · | 6.9 | 7.5 | 4.8 | · | 3.7 | 3.5 | 1.8 | · | 4.1 | 3.0 | 1.3 |
Efficiency
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | |
| Receivables Turnover | · | 2.9 | 3.3 | 2.6 | · | 3.1 | 3.3 | 2.7 | · | 3.3 | 3.4 | 2.9 | · | 3.6 | 3.9 | 2.6 |
Per Share
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $40.09 | $39.79 | $40.13 | · | $39.24 | $38.59 | $36.85 | · | $34.98 | $34.65 | $34.12 | · | $34.15 | $33.51 | $33.26 | |
| Revenue / Share | · | $14.00 | $13.89 | $12.48 | · | $12.19 | $11.66 | $10.67 | · | $10.41 | $9.64 | $8.74 | · | $8.06 | $7.88 | $7.65 | |
| Cash Flow / Share | · | · | · | $3.52 | · | · | · | $2.28 | · | · | · | $2.36 | · | · | · | $1.97 | |
| Cash / Share | · | $4.32 | $1.62 | $7.29 | · | $6.00 | $5.20 | $7.02 | · | $4.76 | $4.63 | $6.50 | · | $7.13 | $4.57 | $7.21 | |
| EPS (TTM) | · | $6.41 | $6.80 | $6.67 | · | $5.98 | $5.32 | $4.32 | · | $2.67 | $2.74 | $2.29 | · | $1.74 | $7.78 | $7.61 |
Valuation (TTM)
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $1.91B | $1.89B | $1.83B | · | $1.74B | $1.69B | $1.63B | · | $1.54B | $1.50B | $1.47B | · | $1.44B | $1.44B | $1.45B | |
| Net Income TTM | · | $234M | $253M | $253M | · | $232M | $208M | $172M | · | $110M | $119M | $103M | · | $75M | $376M | $370M | |
| Market Cap | · | $3.92B | $3.59B | $5.61B | · | $3.67B | $3.39B | $2.85B | · | $1.94B | $2.33B | $1.73B | · | $1.71B | $1.61B | $1.65B | |
| Enterprise Value | · | $4.27B | $4.03B | $5.90B | · | $4.01B | $3.84B | $3.23B | · | $2.41B | $2.84B | $2.16B | · | $2.09B | $2.10B | $2.07B | |
| P/E | · | 18.0 | 15.2 | 23.2 | · | 16.8 | 17.1 | 17.5 | · | 19.3 | 21.5 | 18.7 | · | 22.2 | 4.6 | 4.8 | |
| P/S | · | 2.1 | 1.9 | 3.1 | · | 2.1 | 2.0 | 1.7 | · | 1.3 | 1.6 | 1.2 | · | 1.2 | 1.1 | 1.1 | |
| P/B | · | 2.9 | 2.6 | 3.8 | · | 2.6 | 2.4 | 2.0 | · | 1.5 | 1.7 | 1.3 | · | 1.1 | 1.1 | 1.1 | |
| P / Cash Flow | · | · | · | 43.0 | · | · | · | 31.9 | · | · | · | 17.4 | · | · | · | 18.1 | |
| EV / Revenue | · | 2.2 | 2.1 | 3.2 | · | 2.3 | 2.3 | 2.0 | · | 1.6 | 1.9 | 1.5 | · | 1.4 | 1.5 | 1.4 | |
| Earnings Yield | · | 5.6% | 6.6% | 4.3% | · | 5.9% | 5.9% | 5.7% | · | 5.2% | 4.7% | 5.3% | · | 4.5% | 21.9% | 20.9% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-12-31 |
|---|---|---|---|---|---|
| Revenue | $1.95B | $1.79B | $1.58B | $1.45B | · |
| Operating Margin % | 19.6% | 19.1% | 13.7% | 11.6% | · |
| Net Income | $252M | $237M | $137M | $93M | · |
| Diluted EPS | $7.04 | $6.18 | $3.39 | $2.05 | · |
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | 0.5 | 0.4 | 0.5 | 0.5 | · |
| Current Ratio | 1.1 | 0.8 | 0.9 | 1.1 | · |
| Quick Ratio | 1.0 | 0.7 | 0.7 | 0.9 | · |
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $393M | $288M | $247M | $166M | · |
Institutional owners (13F) 401 filers · $4.5B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 53 (0 vs prior Q) | 30 (-22 vs prior Q) | 142 (+2 vs prior Q) | 135 (+4 vs prior Q) | -171K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $683,177,439 | 5,480,326 | 15.10% | Shares |
| VANGUARD GROUP INC | $449,985,960 | 4,348,951 | 9.94% | Shares |
| FMR LLC | $401,181,165 | 3,218,203 | 8.86% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $297,558,184 | 2,386,958 | 6.57% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $222,235,571 | 1,782,750 | 4.91% | Shares |
| ARIEL INVESTMENTS, LLC | $220,878,073 | 1,771,844 | 4.88% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $183,742,358 | 1,473,948 | 4.06% | Shares |
| STATE STREET CORP | $173,212,203 | 1,389,477 | 3.83% | Shares |
| Capital World Investors | $132,593,736 | 1,063,643 | 2.93% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $111,498,699 | 894,257 | 2.46% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $99,984,176 | 802,055 | 2.21% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $78,581,301 | 630,365 | 1.74% | Shares |
| Boston Partners | $71,229,785 | 567,172 | 1.57% | Shares |
| FRANKLIN RESOURCES INC | $70,714,009 | 567,255 | 1.56% | Shares |
| Alyeska Investment Group, L.P. | $68,807,458 | 551,961 | 1.52% | Shares |
| Fisher Asset Management, LLC | $63,050,035 | 505,776 | 1.39% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $60,245,186 | 483,276 | 1.33% | Shares |
| MORGAN STANLEY | $58,961,768 | 472,980 | 1.30% | Shares |
| NORTHERN TRUST CORP | $54,225,605 | 434,988 | 1.20% | Shares |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | $44,010,839 | 353,047 | 0.97% | Shares |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $37,728,848 | 302,654 | 0.83% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $33,376,692 | 271,952 | 0.74% | Shares |
| TWO SIGMA INVESTMENTS, LP | $32,342,164 | 259,443 | 0.71% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $30,437,360 | 244,163 | 0.67% | Shares |
| Bank of New York Mellon Corp | $28,712,585 | 230,327 | 0.63% | Shares |
| PRINCIPAL FINANCIAL GROUP INC | $26,394,013 | 211,728 | 0.58% | Shares |
| Allianz Asset Management GmbH | $24,804,472 | 198,977 | 0.55% | Shares |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $24,151,629 | 193,740 | 0.53% | Shares |
| Nuveen, LLC | $23,937,712 | 192,024 | 0.53% | Shares |
| SG Capital Management LLC | $22,238,845 | 178,396 | 0.49% | Shares |
| BANK OF AMERICA CORP /DE/ | $21,978,929 | 176,311 | 0.49% | Shares |
| GOLDMAN SACHS GROUP INC | $20,337,780 | 163,146 | 0.45% | Shares |
| TWO SIGMA ADVISERS, LP | $19,876,587 | 192,100 | 0.44% | Shares |
| ALGERT GLOBAL LLC | $19,323,048 | 155,006 | 0.43% | Shares |
| Invesco Ltd. | $18,361,795 | 147,295 | 0.41% | Shares |
| Public Sector Pension Investment Board | $17,393,810 | 139,530 | 0.38% | Shares |
| Corient Private Wealth LP | $17,190,989 | 137,903 | 0.38% | Shares |
| PRUDENTIAL FINANCIAL INC | $15,911,852 | 127,642 | 0.35% | Shares |
| WESTPORT ASSET MANAGEMENT INC | $15,677,117 | 125,759 | 0.35% | Shares |
| MACKENZIE FINANCIAL CORP | $13,510,152 | 108,376 | 0.30% | Shares |
| WELLS FARGO & COMPANY/MN | $12,758,571 | 102,347 | 0.28% | Shares |
| Qube Research & Technologies Ltd | $12,647,380 | 101,455 | 0.28% | Shares |
| RHUMBLINE ADVISERS | $10,647,181 | 85,410 | 0.24% | Shares |
| Legal & General Group Plc | $10,482,784 | 84,091 | 0.23% | Shares |
| LGT CAPITAL PARTNERS LTD. | $10,035,130 | 80,500 | 0.22% | Shares |
| MILLENNIUM MANAGEMENT LLC | $9,671,247 | 77,581 | 0.21% | Shares |
| Foresight Group Ltd Liability Partnership | $9,636,366 | 77,264 | 0.21% | Shares |
| AMERICAN CENTURY COMPANIES INC | $9,436,388 | 75,697 | 0.21% | Shares |
| ALLIANCEBERNSTEIN L.P. | $8,879,782 | 77,048 | 0.20% | Shares |
| LAZARD ASSET MANAGEMENT LLC | $8,696,157 | 69,759 | 0.19% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| International Value Advisers, LLC, Charles de Vaulx ×18 filings | Aug. 7, 2020 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 113 insiders · 51 officers · 26 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Stephen W. Beard, | Chairman & CEO | Aug. 23, 2026 F | 477,464 | 0 | 5 | $-3,938,087 |
| Daniel Hamburger | President and CEO | Aug. 31, 2015 S | 142,136 | 0 | 0 | $0 |
| Robert J. Phelan | Chief Financial Officer | Aug. 23, 2026 F | 56,571 | 0 | 4 | $-2,277,058 |
| Michael O Randolfi | SVP, Chief Financial Officer | Aug. 28, 2020 F | 84,391 | 0 | 0 | $0 |
| Timothy J Wiggins | SVP & Chief Financial Officer | Feb. 25, 2016 S | 44,939 | 0 | 0 | $0 |
| Richard Gunst | Chief Financial Officer | Feb. 1, 2012 M | 9,356 | 0 | 0 | $0 |
| Amelia Manning | President, Chamberlain Univ. | July 15, 2026 A | 4,317 | 0 | 0 | $0 |
| Karen Sue Cox | President, Chamberlain Univ. | May 8, 2026 S | 31,596 | 0 | 1 | $-249,000 |
| Scott Liles | President, Medical and Vet | April 15, 2026 F | 13,103 | 0 | 0 | $0 |
| Evan Trent | President, Adtalem Elevate | Nov. 13, 2025 F | 24,134 | 0 | 0 | $0 |
| Thiago Aguiar Sayao | Group President, Business &Law | Feb. 28, 2020 S | 1,830 | 0 | 0 | $0 |
| Carlos Filgueiras | Group President, Tech/Business | Feb. 13, 2019 S | 11,775 | 0 | 0 | $0 |
| Donna M Loraine | President, Carrington Colleges | Nov. 6, 2018 M | 6,701 | 0 | 0 | $0 |
| Susan Groenwald | President, Chamberlain | Feb. 9, 2018 M | 34,402 | 0 | 0 | $0 |
| John P Roselli | President, Becker Professional | Sept. 1, 2017 S | 13,730 | 0 | 0 | $0 |
| Eric P. Dirst | President, ATGE Shared Ops | Aug. 31, 2017 S | 14,800 | 0 | 0 | $0 |
| Robert A Paul | President, DeVry University | Aug. 25, 2017 M | 28,426 | 0 | 0 | $0 |
| Steven Riehs | President, Med, Prof & Online | Sept. 2, 2016 M | 28,062 | 0 | 0 | $0 |
| Jeffrey Richard Akens | President, Carrington College | Aug. 29, 2015 F | 6,752 | 0 | 0 | $0 |
| Christopher Caywood | President, Online Services | March 1, 2013 F | 7,378 | 0 | 0 | $0 |
| Andrew A Jeon | President, DeVry Medical Int'l | Nov. 2, 2012 F | 5,655 | 0 | 0 | $0 |
| William B. Hughson | President, Medical & | Aug. 29, 2012 A | 2,143 | 0 | 0 | $0 |
| George Montgomery | President, U.S. Education | Aug. 27, 2010 A | · | 0 | 0 | $0 |
| Manjunath Gangadharan | VP, Chief Accounting Officer | Aug. 27, 2026 S | 5,083 | 0 | 1 | $-247,198 |
| Michael Betz | Pres. Walden University & CDO | Aug. 23, 2026 F | 39,172 | 0 | 0 | $0 |
| Douglas G. Beck | SVP, GC, Corp. Sec & ISS | Aug. 23, 2026 F | 33,394 | 0 | 4 | $-2,524,973 |
| Maurice Herrera | SVP - Chief Marketing Officer | Nov. 13, 2025 F | 20,584 | 0 | 0 | $0 |
| Megan Noel | Chief Corp. Affairs Officer | Nov. 12, 2025 A | 2,226 | 0 | 0 | $0 |
| Sara Hill | CHRO | Nov. 12, 2025 A | 10,276 | 0 | 0 | $0 |
| Blake Simpson | SVP, Chief Comms & CA Officer | Dec. 5, 2024 F | 8,795 | 0 | 0 | $0 |
| Steven Tom | SVP Chief Customer Officer | Nov. 13, 2024 A | 13,255 | 0 | 0 | $0 |
| Cheryl James | SVP, CHRO | Feb. 28, 2024 F | 17,485 | 0 | 0 | $0 |
| John W Danaher MD | Pres. - Adtalem Med & Vet | Aug. 25, 2023 F | 38,718 | 0 | 0 | $0 |
| James Raymond Bartholomew | SVP - Chamberlain University | Aug. 26, 2022 F | 6,418 | 0 | 0 | $0 |
| Holland Katherine Alice Boden | Group Pres, Adtalem Health | Aug. 30, 2021 F | 32,148 | 0 | 0 | $0 |
| Fernando Lau | SVP, Chief Marketing Officer | Aug. 28, 2021 F | 19,253 | 0 | 0 | $0 |
| Christopher C Nash | SVP, Chief Information Officer | Aug. 28, 2021 F | 25,741 | 0 | 0 | $0 |
| Donna Jennings | SVP, Human Resources | Aug. 28, 2021 F | 30,898 | 0 | 0 | $0 |
| Chaka M Patterson | SVP and General Counsel | Aug. 28, 2020 F | 5,202 | 0 | 0 | $0 |
| Mehul R Patel | Group Pres, Financial Services | Nov. 7, 2019 F | 11,258 | 0 | 0 | $0 |
| Kathleen Carroll | Vice President, Controller | Aug. 28, 2019 A | 5,497 | 0 | 0 | $0 |
| Lisa M Sodeika | SVP, Corporate Affairs | Aug. 28, 2019 A | 24,151 | 0 | 0 | $0 |
| Patrick J Unzicker | Principal Financial Officer | Aug. 27, 2019 F | 36,360 | 0 | 0 | $0 |
| Catherine C. Anderson | SVP, Strategy & Innovation | Aug. 26, 2019 F | 6,025 | 0 | 0 | $0 |
| Gena L Ashe | SVP, CLO and Secretary | Aug. 23, 2017 A | 4,420 | 0 | 0 | $0 |
| Gregory S Davis | SVP and General Counsel | Sept. 1, 2016 S | 22,433 | 0 | 0 | $0 |
| Adriano Allegrini | VP, Strategy and Bus. Develop. | Aug. 29, 2015 F | 7,004 | 0 | 0 | $0 |
| Sharon Thomas Parrott | SVP, Gov. & Regulatory Affairs | Nov. 5, 2014 A | 5,610 | 0 | 0 | $0 |
| David J Pauldine | Executive Vice President & | April 25, 2014 M | 30,242 | 0 | 0 | $0 |
| Thomas C Shepherd | Executive Vice President and | May 27, 2011 M | 0 | 0 | 0 | $0 |
| Thomas J Vucinic | Sr. Vice President & President | Aug. 27, 2010 A | 258 | 0 | 0 | $0 |
| Michael W Malafronte | Director | Aug. 31, 2026 G | 110,705 | 5 | 0 | $3,844,716 |
| William V Krehbiel | Director | Nov. 13, 2025 F | 16,303 | 0 | 0 | $0 |
| Betty M. Vandenbosch | Director | Nov. 13, 2025 F | 2,584 | 0 | 0 | $0 |
| Kenneth J Phelan | Director | Nov. 13, 2025 F | 19,836 | 1 | 0 | $49,931 |
| Georgette D. Kiser | Director | Nov. 13, 2025 F | 17,481 | 0 | 0 | $0 |
| Lisa W Wardell | Director | Nov. 13, 2025 F | 44,251 | 0 | 0 | $0 |
| Donna J Hrinak | Director | Nov. 13, 2025 F | 8,218 | 0 | 0 | $0 |
| William W Burke | Director | Nov. 13, 2025 F | 10,423 | 0 | 0 | $0 |
| Sharon O'Keefe | Director | Nov. 12, 2025 A | 16,597 | 0 | 0 | $0 |
| Mayur Gupta | Director | Nov. 8, 2024 F | 6,667 | 0 | 0 | $0 |
| Charles Deshazer | Director | Nov. 9, 2023 F | 5,132 | 0 | 0 | $0 |
| James D White | Director | Feb. 11, 2021 P | 13,152 | 0 | 0 | $0 |
| Steven Altschuler | Director | Nov. 6, 2019 A | 6,170 | 0 | 0 | $0 |
| Ann Hart | Director | Nov. 8, 2018 F | 7,117 | 0 | 0 | $0 |
| Fernando Ruiz | Director | Nov. 10, 2016 A | 16,956 | 0 | 0 | $0 |
| David S Brown | Director | Nov. 5, 2016 F | 5,182 | 0 | 0 | $0 |
| Alan G Merten | Director | Nov. 5, 2016 F | 9,302 | 0 | 0 | $0 |
| Connie R Curran | Director | Nov. 7, 2014 F | 13,295 | 0 | 0 | $0 |
| Darren Richard Huston | Director | July 7, 2014 F | 10,436 | 0 | 0 | $0 |
| William T Keevan | Director | Nov. 10, 2013 F | 15,041 | 0 | 0 | $0 |
| Julie A Mcgee | Director | Nov. 10, 2013 F | 24,542 | 0 | 0 | $0 |
| Harold T Shapiro | Director | Nov. 3, 2013 F | 8,879 | 0 | 0 | $0 |
| Gary C Butler | Director | Nov. 3, 2012 F | 4,275 | 0 | 0 | $0 |
| MICROSOFT CORP | Director | Nov. 10, 2009 A | 1,290 | 0 | 0 | $0 |
| KREHBIEL FREDERICK A | Director | Oct. 29, 2008 S | 1,700 | 0 | 0 | $0 |
| Dennis J Keller | 10% owner | Aug. 25, 2010 G | 5,760,787 | 0 | 0 | $0 |
| Lyle Logan | · | Nov. 8, 2022 S | 27,048 | 0 | 0 | $0 |
| Ronald L Taylor | · | Nov. 8, 2018 F | 424,605 | 0 | 0 | $0 |
| Christopher B Begley | · | Nov. 10, 2016 A | 15,057 | 0 | 0 | $0 |
| Charles A Bowsher | · | Jan. 29, 2008 M | 2 | 0 | 0 | $0 |
| Harvey Leffring | · | Nov. 7, 2007 A | · | 0 | 0 | $0 |
| Patrick L Mayers | · | Oct. 30, 2007 S | 2,500 | 0 | 0 | $0 |
| Paul E. Eppen | · | Oct. 29, 2007 M | 7,477 | 0 | 0 | $0 |
| Robert C Mccormack | · | Oct. 29, 2007 M | 1,784 | 0 | 0 | $0 |
| Norman M Levine | · | Aug. 17, 2007 S | 10,500 | 0 | 0 | $0 |
| Kenneth Rutkowski | · | Feb. 9, 2007 M | 7,514 | 0 | 0 | $0 |
| John O Skubiak | · | Feb. 8, 2007 G | 29,575 | 0 | 0 | $0 |
| Rose Marie Dishman | · | Feb. 8, 2007 S | 0 | 0 | 0 | $0 |
| Jack Calabro | · | Jan. 31, 2007 S | 0 | 0 | 0 | $0 |
| John M Holbrook | · | Oct. 3, 2006 A | · | 0 | 0 | $0 |
| Robert C Le Valley | · | Oct. 3, 2006 A | 0 | 0 | 0 | $0 |
| Gerald A Murphy | · | Oct. 3, 2006 A | 3,125 | 0 | 0 | $0 |
| James W Kho | · | Oct. 3, 2006 A | · | 0 | 0 | $0 |
| Galen Graham | · | Oct. 3, 2006 A | 489 | 0 | 0 | $0 |
| James A Dugan | · | Oct. 3, 2006 A | 0 | 0 | 0 | $0 |
| Jerry R Dill | · | Oct. 3, 2006 A | 400 | 0 | 0 | $0 |
| Thomas Babel | · | Oct. 3, 2006 A | · | 0 | 0 | $0 |
| Timothy H Ricordati | · | Sept. 13, 2006 M | 12,400 | 0 | 0 | $0 |
| Timothy J Joyce | · | Dec. 22, 2005 S | 2,534 | 0 | 0 | $0 |
| Gerald J Wawrzynek | · | Dec. 8, 2005 M | 5,500 | 0 | 0 | $0 |
| George W Fisher | · | Nov. 16, 2005 M | 1,640 | 0 | 0 | $0 |
| Marilynn J Cason | · | Aug. 26, 2005 G | 8,961 | 0 | 0 | $0 |
| Fredric M Weber | · | May 25, 2005 M | 1,000 | 0 | 0 | $0 |
| Hugo J Melvoin | · | April 29, 2005 G | 7,412 | 0 | 0 | $0 |
| David M Webster | · | April 27, 2005 A | · | 0 | 0 | $0 |
| Edward J Steffes | · | April 27, 2005 S | 0 | 0 | 0 | $0 |
| Thurston E Manning | · | Feb. 15, 2005 S | 27,450 | 0 | 0 | $0 |
| Michael J Alexander | · | Aug. 10, 2004 A | · | 0 | 0 | $0 |
| Bruno R Lacaria | · | Aug. 10, 2004 A | · | 0 | 0 | $0 |
| Cecil Horst | · | Aug. 10, 2004 A | 2,025 | 0 | 0 | $0 |
| Ronald Baron | · | Aug. 20, 2003 S | 58,898 | 0 | 0 | $0 |
| Timothy E Foster | · | Aug. 15, 2003 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 61 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| PSCD · Invesco Exchange-Traded Fund Trust … | 1.87% | 3,441 SH | Oct. 1, 2026 | Daily |
| PSL · Invesco Exchange-Traded Fund Trust | 1.66% | 10,434 SH | Oct. 1, 2026 | Daily |
| CAFG · Pacer Funds Trust | 1.07% | 2,587 NS | July 31, 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 1.03% | 29,835 NS | July 31, 2026 | N-PORT |
| MYLD · Cambria ETF Trust | 0.95% | 2,595 NS | July 31, 2026 | N-PORT |
| XSHQ · Invesco Exchange-Traded Fund Trust … | 0.90% | 21,068 SH | Oct. 1, 2026 | Daily |
| RZG · Invesco Exchange-Traded Fund Trust | 0.86% | 8,402 SH | Oct. 1, 2026 | Daily |
| JSMD · Janus Detroit Street Trust | 0.74% | 62,173 NS | July 31, 2026 | N-PORT |
| VIOG · VANGUARD ADMIRAL FUNDS | 0.46% | 40,509 SH | Aug. 19, 2026 | Daily |
| SMDX · Tidal Trust III | 0.34% | 3,536 NS | July 31, 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0.32% | 33,449 NS | July 31, 2026 | N-PORT |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0.28% | 5,402 SH | Oct. 1, 2026 | Daily |
| IWO · iShares Trust | 0.28% | 323,692 SH | Sept. 11, 2026 | Daily |
| FYC · First Trust Exchange-Traded AlphaDE… | 0.27% | 28,163 NS | July 31, 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.25% | 36,861 SH | Aug. 19, 2026 | Daily |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.23% | 119,030 SH | Aug. 19, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.23% | 50,636 SH | Oct. 1, 2026 | Daily |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0.22% | 10,374 NS | July 31, 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.20% | 230,892 NS | July 31, 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.20% | 4,269 SH | Oct. 1, 2026 | Daily |
| BKSE · BNY Mellon ETF Trust | 0.19% | 1,310 NS | July 31, 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.16% | 9,079 NS | July 31, 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.15% | 30,619 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.14% | 882,577 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.14% | 16,493 NS | July 31, 2026 | N-PORT |
| ISCG · iShares Trust | 0.14% | 10,597 SH | Sept. 11, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.13% | 198,216 SH | Aug. 19, 2026 | Daily |
| FDIS · FIDELITY COVINGTON TRUST | 0.13% | 17,290 NS | July 31, 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0.12% | 19,657 SH | Oct. 1, 2026 | Daily |
| VFQY · VANGUARD WELLINGTON FUND | 0.12% | 4,599 SH | Aug. 19, 2026 | Daily |
| VCR · VANGUARD WORLD FUND | 0.12% | 67,714 SH | Aug. 19, 2026 | Daily |
| PKW · Invesco Exchange-Traded Fund Trust | 0.11% | 14,767 SH | Oct. 1, 2026 | Daily |
| VFMF · VANGUARD WELLINGTON FUND | 0.10% | 5,421 SH | Aug. 19, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.09% | 111,792 NS | July 31, 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.09% | 470,701 SH | Aug. 19, 2026 | Daily |
| ESML · iShares Trust | 0.07% | 16,800 SH | Sept. 11, 2026 | Daily |
| FYX · First Trust Exchange-Traded AlphaDE… | 0.06% | 6,997 NS | July 31, 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.06% | 2,549 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.05% | 390,261 SH | Aug. 19, 2026 | Daily |
| VB · VANGUARD INDEX FUNDS | 0.05% | 741,686 SH | Aug. 19, 2026 | Daily |
| DFSV · Dimensional ETF Trust | 0.04% | 27,984 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.04% | 1,783 NS | July 31, 2026 | N-PORT |
| WSML · iShares Trust | 0.04% | 2,071 SH | Sept. 11, 2026 | Daily |
| DFUV · Dimensional ETF Trust | 0.02% | 30,155 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.02% | 91,061 NS | July 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.02% | 3,775 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 3,622 NS | July 31, 2026 | N-PORT |
| TILT · FlexShares Trust | 0.01% | 2,106 NS | July 31, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.01% | 1,024,746 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.01% | 2,840 SH | Aug. 19, 2026 | Daily |
| ESGV · VANGUARD WORLD FUND | 0.01% | 7,618 SH | Aug. 19, 2026 | Daily |
| DFAU · Dimensional ETF Trust | 0.01% | 7,798 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.01% | 10,330 NS | July 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.01% | 44,952 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.01% | 9,317 SH | Sept. 11, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.00% | 25,773 SH | Aug. 19, 2026 | Daily |
| IJR · iShares Trust | · | 2,076,826 SH | Sept. 10, 2026 | Daily |
| IJT · iShares Trust | · | 321,953 SH | Sept. 9, 2026 | Daily |
| XJR · iShares Trust | · | 4,693 SH | Aug. 31, 2026 | Daily |
| ISCB · iShares Trust | · | 1,501 SH | Sept. 11, 2026 | Daily |
| SMLF · iShares Trust | · | 41,983 SH | Sept. 11, 2026 | Daily |
CVSA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
4 analysts · 2026-09-29Mean target $159.50 +27.1%
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CVSA | $4.24B | 17.7 | 9.3% | 12.9% | 17.8% | · |
| DUOL | $8.18B | 20.5 | 38.7% | 39.9% | 35.6% | 72.2% |
| LAUR | $4.81B | 17.8 | 8.6% | 16.6% | 26.2% | · |
| GHC | · | 16.5 | 2.5% | 5.9% | 6.5% | · |
| LOPE | $4.56B | 21.6 | 7.1% | 19.5% | 28.3% | · |
| LRN | $3.58B | 12.1 | 4.7% | 13.4% | 21.3% | 37.8% |
| BFAM | $5.64B | 30.2 | 9.2% | 6.6% | 14.1% | 23.8% |
| MH | $2.62B | 72.1 | 0.07% | 1.7% | 4.6% | 80.9% |
| PRDO | $1.83B | 12.1 | 24.2% | 18.9% | 16.3% | · |
| STRA | $1.84B | 14.8 | 4.0% | 10.0% | 7.6% | · |
| COUR | · | -23.7 | 9.0% | · | · | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.